A nationally recognized healthcare executive, Brad is responsible for guiding the growth and strategy of AON. Since its launch, Brad has grown the network in 14 states with over 85 physicians in just two years. Under his leadership, AON’s network continues to expand at a steady pace. He is committed to helping community oncology practices across the U.S. achieve long-term options for success.

In his role as Florida Cancer Specialists (FCS) Chief Executive Officer from 2009 to 2020, Brad led the growth of the practice from 50 to more than 240 physicians, expanded the service offerings, developed and implemented the organization’s mission to provide world-class cancer care in community-based settings close to home.

Brad brings more than 30 years of physician practice management experience to his role with AON. In addition to his FCS experience, he spent seven years as CFO and CEO of several PhyCor multi-specialty physician practices, as well as seven years at US Oncology. During his tenure at US Oncology, Brad served as the Executive Director of Practice Operations for Texas Oncology. In addition, Brad was the President of Crozer Keystone Health Network, a multi-specialty physician group practice, and COO for Physician Oncology Services, a prostate cancer treatment network in Georgia, Indiana and Kentucky.

After graduating with a bachelor’s degree in accounting and passing the CPA exam, Brad spent three years as an auditor and consultant at Big 8 firms Arthur Andersen and Coopers and Lybrand; he later earned his MBA from the University of Pittsburgh, while working at the University of Pittsburgh Medical Center.

Brad is committed to his community and serves as a volunteer with Big Brothers/Big Sisters. He also served as Chairman of the Board for the Florida Cancer Specialists Foundation from 2010 to 2018, which provides non-medical financial assistance to qualified cancer patients in Florida. Additionally, Brad served as the 2016 and 2017 Florida Chair of American Cancer Society’s CEO’s Against Cancer, a program of the American Cancer Society.

A nationally recognized healthcare executive with more than 25 years’ experience and expertise, Todd is responsible for overseeing AON’s day-to-day operations, including practice operations, information technology, care management, oversight of central ancillaries and research, and marketing.

In his role as Florida Cancer Specialists (FCS) Chief Operating Officer, he is responsible for the day-to-day operations within the corporate office and nearly 100 locations throughout Florida.

Prior to his role as COO of FCS in 2011, Todd was Senior Vice President and Chief Information Officer for US Oncology. As part of the senior management team, Todd helped set organizational goals and objectives, oversaw strategic project prioritization, and led tactical execution of company-wide initiatives. He was also responsible for all day-to-day operational aspects of information technology and strategic direction for the information technology needs of the organization. While Senior Vice President and Chief Information Officer, he was named to the Information Week 500 and received the ComputerWorld/IDG Laureate Award, recognizing individuals and organizations that use information technology to benefit society. During his tenure at US Oncology, he also held positions as the Director of Enterprise Applications and Vice President of Information Systems. Todd’s consulting and management experience in healthcare information technology includes positions with Datamedic Corporation (acquired by VitalWorks and later Amicas Corporation), Multum Corporation (acquired by Cerner Corporation), and MedE America (acquired by WebMD and later HLTH Corporation).

Todd received a bachelor’s degree in health policy and administration from Pennsylvania State University. Todd has presented at national industry conferences including multiple Community Oncology Alliance (COA) conferences as well as national and regional information technology conferences.

Nate oversees finance and accounting operations, business planning and investments, and fiscal compliance policy and practices. Nate brings more than a decade of domain expertise and transaction experience to AON, having advised emerging growth and multi-national healthcare companies on the evaluation and execution of strategic capital investments and growth opportunities.

Prior to joining AON, Nate served as a member of Bank of America Merrill Lynch’s healthcare investment banking group in New York. After earning his undergraduate degree in economics from Columbia University, he started his career on the trading floor at Merrill Lynch. He later received his MBA in finance from Columbia Business School and has since held senior leadership positions as an investment banker and strategic advisor.

His community service reflects his deep commitment to assisting and advocating for individuals with disabilities and those who are homeless. He is also a frequent contributor and benefactor of animal welfare activities. Nate and his wife, Chelsea, have one daughter and an adopted rescue dog, Bailey.

After receiving his medical degree from Ross University School of Medicine in the West Indies, Dr. Patel completed a residency in internal medicine at the Medical College of Georgia in Augusta, Ga. and at Vanderbilt University Medical Center in Nashville, Tenn.

Dr. Patel is Board certified in medical oncology and hematology. Dr. Patel is deeply committed to clinical trials research, and he previously served as director of clinical trials for an Institutional Review Board in Gaston, N.C., with responsibility for protecting the rights and welfare of patients involved in research. He has been published in several prestigious journals, including the International Journal of Cancer.

Prior to entering clinical practice, he served as a teaching assistant in biochemistry and anatomy at Vanderbilt University and as an instructor of hematology/oncology to second-year medical students at Meharry Medical College in Nashville.

Originally from New York, Dr. Ambinder is a highly respected physician who holds the distinction of being the longest practicing oncologist in Central Florida. After graduating from Yale University, Dr. Ambinder attended medical school at Columbia University College of Physicians and Surgeons. He is Board certified by the American Board of Internal Medicine, American Board of Hematology and American Board of Neoplastic Diseases. Dr. Ambinder has served as a former Assistant Consulting Professor of Medicine at Duke University Medical Center, where he was also a member of the Board of Overseers of the Cancer Center and Board Memberships for the Florida Hospital Foundation.

Shelly is responsible for overseeing marketing, community outreach, physician recruitment and referral base management initiatives. She brings more than 30 years of healthcare industry and business-to-consumer experience to her position and is adept in all aspects of sales, marketing, operations, communications, training and customer service.

Prior to joining Florida Cancer Specialists (FCS) in 2012, Shelly was Vice President of Marketing & Sales for Vantage Oncology, a radiation oncology organization based in Atlanta, Ga. While at Vantage, she was responsible for developing and implementing strategies to increase patient volume as well as the profile of the company. Shelly was formerly the Chief Administrative Officer for Park ‘N Fly and previously held positions with increasing sales and marketing responsibilities at The Care Group, Roche Professional Service Centers and Sandoz Nutrition.

Shelly received a Bachelor of Science degree in marketing from Lehigh University, as well as a Global Leadership designation from the University of Pennsylvania’s Wharton School.

Dedicated to increasing cancer awareness and education, Shelly currently serves as Secretary on the Board of Directors of the Florida Cancer Specialists Foundation, Jack & Jill Late Stage Cancer Foundation, Leukemia & Lymphoma Society Suncoast Chapter Board of Trustees as the Chair, American Cancer Society’s CEO’s Against Cancer and as Chair of the Marketing Committee for the Florida Society of Clinical Oncology (FLASCO). Shelly also was 2013 Co-Chair of American Cancer Society’s Making Strides Against Breast Cancer in Sarasota/Manatee and was named the 2014 Leukemia & Lymphoma Society’s Woman of the Year. In addition, she actively participates on the Advisory Committee of Chief Marketing Officer (CMO) Institute and Women of the Tampa Bay Buccaneers (founding member) and was 2018 Tampa Bay Business Journal’s Businesswoman of the Year Finalist.

Shelly has presented and participated in panel discussions at national conferences such as the 2019 Digital Healthcare Transformation Assembly.

A recognized leader in clinical research, Dr. Reynolds has been an invited speaker at several national and international conferences. His research has been extensively published in such prestigious journals as Blood, Cancer, Journal of Clinical Oncology and Journal of Thoracic Oncology.

During his distinguished career, Dr. Reynolds has been recognized with numerous awards and acknowledgements. He has provided physician leadership as a member of several national committees and advisory boards. Currently, he serves on the Education Committee of the American Society of Clinical Oncology (ASCO) and the Community Practice Committee of the International Association for the Study of Lung Cancer.

Board certified in medical oncology and hematology, he attended medical school at the University of Miami and at Washington University in St. Louis, Mo.

Dr. Orman received his BA in biology from St. Louis University and his Doctorate of Medicine from the University of Tennessee Center for the Health Sciences, Memphis, Tenn. He completed his internship and residency training in internal medicine and fulfilled a research year in immunology at the University of Tennessee. He was awarded his Fellowship in Hematology & Oncology at the George Washington University Medical Center, District of Columbia. Dr. Orman has participated as a sub-investigator in nearly 100 clinical research trials and has been published in Cancer Genetics and Cytogenetics, Archives of Internal Medicine, and the Journal of Clinical Oncology.

In 1985, he joined Venice Oncology Associates which later merged with Florida Cancer Specialists in 1998. During his career, Dr. Orman has served on the Board of Directors for the Florida Society of Clinical Oncology, on the Board of Directors of Venice Regional Medical Center and as Chief of Staff of Venice Regional. He has been the recipient of the “Hope Award” for the Wellness Community of Southwest Florida.

Dr. Orman retired from clinical practice in 2017 but continued his role as Assistant Managing Partner of Florida Cancer Specialists. Currently, his sole focus is serving as Chairman of the inaugural Board of Directors of American Oncology Network, LLC, and will continue to lead the organization in that capacity.

Paul has nearly 10 years of experience in both clinical and community oncology industry leadership roles. Prior to joining AON in 2019 Paul was the Group Purchasing Organization (GPO) National Director of Sales Operations and Corporate Accounts at ION Solutions and Oncology Supply. In this role, he and his team created tools and implemented processes to enable oncology practices to evaluate, track, monitor and perform effectively in compliance with their drug contracts. Also, Paul worked directly with AON on their strategic opportunities to leverage the size and scope to achieve key performance initiatives with ION, Oncology Supply and their pharmaceutical partners. During his tenure with ION, Paul also held positions of Strategic Account Manager and East Coast Sales Director directly and indirectly managing the individual contract portfolios of hundreds of practices in the network.

Formerly, Paul was a published pathology researcher and previously a financial analyst for a large oncology practice in New York City. He continues to leverage his clinical, contracting and analytical knowledge in community oncology to help keep world-class care close to home.

Paul earned his bachelor’s in psychology at the University of California, San Diego and is currently working on his master’s in applied math at Hunter College in New York City, where he lives in a tiny apartment with his wife Suzanne and two children.

Joyce oversees HR operations and human capital strategy across the organization. With over 20 years’ experience in international human resources, consulting, and operations, she brings expertise in strategic human capital management, start-ups, mergers and acquisitions, culture transformation, and leadership development. Prior to joining AON, Joyce worked at Adventist Health System for eight years, where she most recently served as a member of the senior executive team at Florida Hospital Tampa since 2015, and was a founding member of the Florida Hospital Wesley Chapel’s executive team in 2011, where she was instrumental in the opening of a greenfield hospital, including the design and construction of a medically based wellness center.

Joyce’s prior experience includes progressive HR leadership roles at Advex Advancing Excellence, Cogeco Canada, Quartet Service Corporation, and Algorithmics (Americas, S. Europe & EMEA). She has helped organizations achieve such recognition as “Top 50 Best Managed Private Companies”, “Employer of Choice”, “Tampa Bay Times Top Workplace”, and the “American Heart Gold Workplace Health Award”. She holds a Bachelor of Arts from Ryerson University and is pursuing a master’s in healthcare administration. She is a certified Professional in Human Resources (PHR/SHRM-CP) and a Certified Professional Behavioral Analyst (CPBA). Joyce enjoys spending time with her family, traveling, and volunteering.

Mark serves as Chief Information Officer for the AON Advisory Group and is responsible for overseeing information technology across the American Oncology Network (AON) organization. Prior to joining AON, Mark served for nine years as Vice President of information technology at Promise Healthcare, Inc., the nation’s 5th largest long-term acute care (LTAC) hospital company, where he was responsible for the leadership and planning of information technology for all the Promise Healthcare locations. Before joining Promise Healthcare, Mark worked as an Operations Analyst for The GEO Group, an international private prison management company with over 100 facilities.

A native of Poland, Mark began his career as a teacher of literature and holds a Master of Arts degree in literature from the University of Wroclaw in Poland. After moving to the United States, he entered the IT field and transitioned to healthcare IT where he quickly embraced the impact technology would have on healthcare operations and patient care. Mark specializes in envisioning, managing and supporting IT solutions that support ongoing improvement and continuity of high-quality patient care. Mark and his wife Iwona reside in Fort Myers and enjoy travel, and all beach related activities.

Sarah is responsible for all aspects of revenue cycle management while delivering a positive patient experience. Sarah’s responsibilities also include fostering payer partnerships while leading AON’s value-based care initiatives to enhance innovative payment programs to support the delivery of high-quality cancer care.

In her role as Florida Cancer Specialists’ (FCS) Chief Revenue Officer, she has held several finance-related positions and she provided strategic direction to various departments that lead to increasing responsibility such as patient financial services, insurance collections, and cash applications while developing positive payer relationships and spearheading multiple partnerships with innovation value-based agreements as well as leading the partnership with CMMI through the implementation of the Oncology Care Model (OCM) to all of FCS’ cancer centers throughout the state of Florida.

Sarah serves as Clinical Practice Committee Member for the Florida Association of Clinical Oncology (FLASCO) and works closely with the Community Oncology Alliance (COA) on reimbursement and practice transformation strategies towards value-based care. She has been recognized by the Florida Association of Clinical Oncology (FLASCO) as the inaugural recipient of the Distinguished Service Award for her continued support of facilitating resolution of reimbursement issues for oncologists in Florida.

Sarah holds a Bachelor of Science degree in business management from Nova Southeastern University and an MBA degree from Western Governors University with a concentration in healthcare management.

Sarah has been quoted and interviewed by the American Journal of Managed Care (AJMC) on various topics ranging from OCM to enhancing the revenue cycle process.

Dr. Spitz graduated from medical school at the Medical University of South Carolina, located in Charleston, S.C. and was awarded a Fellowship in Oncology/Hematology at the Bellevue Medical Center located in New York, N.Y. He is Board certified in medical oncology, hematology and internal medicine. Dr. Spitz served on the Board of Directors for the Palm Beach County Chapter of the American Cancer Society and on the National Medical Advisory Board of the National Ovarian Cancer Coalition of Palm Beach.